Robert A. Berman
CEO, Hancock Jaffe Laboratories, Inc.
Mr. Berman is the Chief Executive Officer of Hancock Jaffe
Laboratories, Inc. (Nasdaq: HJLI) and is a member of its Board of Directors. He has
experience in a broad variety of areas including healthcare, finance, acquisitions,
marketing, compliance, turnarounds, and the development and licensing of emerging
technologies. From September 2012 until July 2017, he served as the President, Chief
Executive Officer, and a member of the Board of Directors of ITUS Corporation (now
Anixa Biosciences), a Nasdaq listed company that is developing a liquid biopsy
technology for early cancer detection. Prior to ITUS, Mr. Berman was the CEO of VIZ
Technologies, a start-up company which developed and licensed a beverage
dispensing cap, and he was the founder of IP Dispute Resolution Corporation, a
company focused on intellectual property licensing. From 2000 to March 2007 Mr.
Berman was the Chief Operating Officer and General Counsel of Acacia Research
Corporation, which became the preeminent, publicly traded company for licensing and
enforcing patented technologies. Prior to moving to California, Mr. Berman was a
Director of Business Development at QVC where started an in-house record label, and
developed and selected products for on-air sales and distribution. He started his career
at the law firm of Blank Rome. He has a B.S. in Entrepreneurial Management from the
Wharton School of the University of Pennsylvania and holds a J.D. from the
Northwestern University School of Law, where he is an adjunct faculty member.